Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
Background No meta-analysis is yet available for the risk of metabolic syndrome (MetS) following androgen deprivation therapy (ADT) for men with prostate cancer. To summarize the evidence for the link between ADT and MetS or its components quantitatively with a meta-analysis including all studies pu...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Revisão |
| Langue: | anglais |
| Publié: |
2015
|
| Accès en ligne: | https://doi.org/10.1371/journal.pone.0117344 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117344&type=printable |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|